Global Vaccine Contract Manufacturing Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Vaccine Contract Manufacturing Market is expected to grow from USD 1,736.09 Million in 2018 to USD 3,865.98 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.11%.
The positioning of the Global Vaccine Contract Manufacturing Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Contract Manufacturing Market including are Ajinomoto Althea, Inc., Cytovance Biologics, FUJIFILM Diosynth Biotechnologies, LONZA, Merck KGaA, Albany Molecular Research, Inc., Catalent, Inc., Cobra Bio, ICON plc., IDT Biologika, KBI Biopharma, Paragon Bioservices, Inc., Pharmaceutical Product Development, LLC, and PRA Health Sciences.
On the basis of Type, the Global Vaccine Contract Manufacturing Market is studied across Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine, Subunit Vaccines, and Toxoid Vaccines.
On the basis of Function, the Global Vaccine Contract Manufacturing Market is studied across Downstream and Upstream.
On the basis of Applications, the Global Vaccine Contract Manufacturing Market is studied across Human Use and Veterinary.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Vaccine Contract Manufacturing Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Vaccine Contract Manufacturing Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Vaccine Contract Manufacturing Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Vaccine Contract Manufacturing Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Vaccine Contract Manufacturing Market
The report answers questions such as:
1. What is the market size of Vaccine Contract Manufacturing market in the Global?
2. What are the factors that affect the growth in the Global Vaccine Contract Manufacturing Market over the forecast period?
3. What is the competitive position in the Global Vaccine Contract Manufacturing Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Vaccine Contract Manufacturing Market?
5. What are the opportunities in the Global Vaccine Contract Manufacturing Market?
6. What are the modes of entering the Global Vaccine Contract Manufacturing Market?
The positioning of the Global Vaccine Contract Manufacturing Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Contract Manufacturing Market including are Ajinomoto Althea, Inc., Cytovance Biologics, FUJIFILM Diosynth Biotechnologies, LONZA, Merck KGaA, Albany Molecular Research, Inc., Catalent, Inc., Cobra Bio, ICON plc., IDT Biologika, KBI Biopharma, Paragon Bioservices, Inc., Pharmaceutical Product Development, LLC, and PRA Health Sciences.
On the basis of Type, the Global Vaccine Contract Manufacturing Market is studied across Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine, Subunit Vaccines, and Toxoid Vaccines.
On the basis of Function, the Global Vaccine Contract Manufacturing Market is studied across Downstream and Upstream.
On the basis of Applications, the Global Vaccine Contract Manufacturing Market is studied across Human Use and Veterinary.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Vaccine Contract Manufacturing Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Vaccine Contract Manufacturing Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Vaccine Contract Manufacturing Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Vaccine Contract Manufacturing Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Vaccine Contract Manufacturing Market
The report answers questions such as:
1. What is the market size of Vaccine Contract Manufacturing market in the Global?
2. What are the factors that affect the growth in the Global Vaccine Contract Manufacturing Market over the forecast period?
3. What is the competitive position in the Global Vaccine Contract Manufacturing Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Vaccine Contract Manufacturing Market?
5. What are the opportunities in the Global Vaccine Contract Manufacturing Market?
6. What are the modes of entering the Global Vaccine Contract Manufacturing Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Vaccine Contract Manufacturing Market
3.2. Opportunities in the Vaccine Contract Manufacturing Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing demand for vaccines leading to capacity expansion by contract manufacturers
4.2.1.2. Paradigm shift toward cell-based vaccine production
4.2.1.3. Key advantages such as cost and time saving offered by contract services
4.2.1.4. Vaccination coverage across the globe
4.2.2. Restraints
4.2.2.1. Limited outsourcing by well-established vaccine manufacturers
4.2.3. Opportunities
4.2.3.1. Rising global demand to cater to the growing population of varied age groups.
4.2.3.2. Innovation and robust vaccine pipeline
4.2.4. Challenges
4.2.4.1. Pharma companies manufacturing operations in-house to gain strategic control
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY TYPE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Attenuated Vaccine
5.4. DNA Vaccines
5.5. Inactivated Vaccine
5.6. Subunit Vaccines
5.7. Toxoid Vaccines
6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY FUNCTION
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Downstream
6.3.1. Analytical & QC studies
6.3.2. Fill & Finish Operations
6.3.3. Packaging
6.4. Upstream
6.4.1. Bacterial expression systems
6.4.2. Baculovirus/insect expression systems
6.4.3. Mammalian expression systems
6.4.4. Yeast expression systems
7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATIONS
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Human Use
7.4. Veterinary
8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Vaccine Contract Manufacturing Market
9.2. Market Vendor Ranking Analysis for Global Vaccine Contract Manufacturing Market
9.3. Competitive News Feed Analysis for Global Vaccine Contract Manufacturing Market
10. COMPANY USABILITY PROFILES
10.1. Ajinomoto Althea, Inc.
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Cytovance Biologics
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. FUJIFILM Diosynth Biotechnologies
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. LONZA
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Merck KGaA
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Albany Molecular Research, Inc.
10.7. Catalent, Inc.
10.8. Cobra Bio
10.9. ICON plc.
10.10. IDT Biologika
10.11. KBI Biopharma
10.12. PRA Health Sciences
10.13. Paragon Bioservices, Inc.
10.14. Pharmaceutical Product Development, LLC
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Vaccine Contract Manufacturing Market
3.2. Opportunities in the Vaccine Contract Manufacturing Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing demand for vaccines leading to capacity expansion by contract manufacturers
4.2.1.2. Paradigm shift toward cell-based vaccine production
4.2.1.3. Key advantages such as cost and time saving offered by contract services
4.2.1.4. Vaccination coverage across the globe
4.2.2. Restraints
4.2.2.1. Limited outsourcing by well-established vaccine manufacturers
4.2.3. Opportunities
4.2.3.1. Rising global demand to cater to the growing population of varied age groups.
4.2.3.2. Innovation and robust vaccine pipeline
4.2.4. Challenges
4.2.4.1. Pharma companies manufacturing operations in-house to gain strategic control
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY TYPE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Attenuated Vaccine
5.4. DNA Vaccines
5.5. Inactivated Vaccine
5.6. Subunit Vaccines
5.7. Toxoid Vaccines
6. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY FUNCTION
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Downstream
6.3.1. Analytical & QC studies
6.3.2. Fill & Finish Operations
6.3.3. Packaging
6.4. Upstream
6.4.1. Bacterial expression systems
6.4.2. Baculovirus/insect expression systems
6.4.3. Mammalian expression systems
6.4.4. Yeast expression systems
7. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATIONS
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Human Use
7.4. Veterinary
8. GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Vaccine Contract Manufacturing Market
9.2. Market Vendor Ranking Analysis for Global Vaccine Contract Manufacturing Market
9.3. Competitive News Feed Analysis for Global Vaccine Contract Manufacturing Market
10. COMPANY USABILITY PROFILES
10.1. Ajinomoto Althea, Inc.
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Cytovance Biologics
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. FUJIFILM Diosynth Biotechnologies
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. LONZA
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Merck KGaA
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Albany Molecular Research, Inc.
10.7. Catalent, Inc.
10.8. Cobra Bio
10.9. ICON plc.
10.10. IDT Biologika
10.11. KBI Biopharma
10.12. PRA Health Sciences
10.13. Paragon Bioservices, Inc.
10.14. Pharmaceutical Product Development, LLC
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
